Jurjen Versluis

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Bone marrow transplantation

Cancer medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Marlen Metzner, Ariel Wang, Patrycja Gradowska, Abin Thomas, Niels Asger Jakobsen, Alison Kennedy, Rachel Moore, Emma Boertjes, Christian M Vonk, Francois G Kavelaars, Melissa Rijken, Amanda Gilkes, Claire Schwab, H Berna Beverloo, Markus Gabriel Manz, Otto Visser, Catharina H M J Van Elssen, Okke de Weerdt, Lidwine W Tick, Bart J Biemond, Marie-Christiane Vekemans, Sylvie D Freeman, Christine J Harrison, Jonathan Alistair Cook, Mike Dennis, Stephen Knapper, Ian Thomas, Charles F Craddock, Gert J Ossenkoppele, Bob Löwenberg, Nigel H Russell, Peter J M Valk, Paresh Vyas
Risk Stratification in Older Intensively Treated Patients With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Rama Al Hamed, Myriam Labopin, De-Pei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob R Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz Caballer, Didier Blaise, Péter Reményi, Urs Schanz, Aleksandra Holowiecka, Norbert-Claude Gorin, Fabio Ciceri, Florent Malard
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. Bone marrow transplantation (2024)
Maud B A van der Kleij, Niels A D Guchelaar, Ron H J Mathijssen, Jurjen Versluis, Alwin D R Huitema, Stijn L W Koolen, Neeltje Steeghs
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. Clinical pharmacokinetics (2023)
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Pal Remenyi, Edouard Forcade, Nicolaus M Kröger, Gerard Sociè, Charles F Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Aleksandra Holowiecka, Arnon Nagler, Fabio Ciceri, Florent Malard
Improved post-transplant outcomes in recent years for AML patients with FLT3-ITD and wild-type NPM1: a report from the EBMT acute leukemia working party. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jurjen Versluis, Wael Saber, Harrison K Tsai, Christopher J Gibson, Laura W Dillon, Asmita Mishra, Joseph P McGuirk, Richard T Maziarz, Peter Westervelt, Pranay S Hegde, Devdeep Mukherjee, Michael J Martens, Brent R Logan, Mary M Horowitz, Christopher S Hourigan, Ryotaro Nakamura, Corey S Cutler, R Coleman Lindsley, null null
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexandros Spirydonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles F Craddock, Eva Maria Wagner-Drouet, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald G Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus M Kröger, Victoria Potter, Edouard Forcade, Jakob R Passweg, Régis Peffault de Latour, Johan A Maertens, Keith M O Wilson, Jean Henri Bourhis, Juergen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin P Savani, Arnon Nagler, Fabio Ciceri, Florent Malard
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Jaime Sanz Caballer, Myriam Labopin, Thomas Pabst, Jurjen Versluis, Gwendolyn Van Gorkom, Ellen Meijer, Tobias Gedde-Dahl, Juan Montoro Gómez, William Arcese, José Antonio Pérez-Simón, Nicolaas Schaap, Johan Maertens, Radovan Vrhovac, Francesco Lanza, Norbert-Claude Gorin, Florent Malard, Fabio Ciceri
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire, Mark G Faber, Rahul S Vedula, Anne Charles, Kevin M Copson, Shai Shimony, Alon Rozental, Pavan K Bendapudi, Ofir Wolach, Elizabeth A Griffiths, James E Thompson, Richard M Stone, Daniel J DeAngelo, Donna Neuberg, Marlise R Luskin, Eunice S Wang, R Coleman Lindsley
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood advances 6 (9) (2022)
Shernan G Holtan, Jurjen Versluis, Daniel J Weisdorf, Jan J Cornelissen
Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (5) (2021)
Arnon Nagler, Fréderic Baron, Myriam Labopin, Emmanuel Polge, Jordi Esteve, Ali Bazarbachi, Eolia Brissot, Gesine Bug, Fabio Ciceri, Sebastian Giebel, Maria H Gilleece, Norbert-Claude Gorin, Francesco Lanza, Zinaida Peric, Annalisa Ruggeri, Jaime Sanz Caballer, Bipin P Savani, Christoph Schmid, Roni Shouval, Alexandros Spirydonidis, Jurjen Versluis, Mohamad Mohty
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT. Bone marrow transplantation 56 (1) (2020)